By broadening our understanding and predictive capabilities, this groundbreaking study provides a substantial contribution to the field of adrenal insufficiency research and enhances the standard of care for patients receiving PD-1/PD-L1 inhibitors. The gene discussed is PDCD1; the disease is Adrenal insufficiency.